Syncope and Atypical Chest Pain in an Intercollegiate Wrestler: A Case Report

Journal of Athletic Training

Volumn 34, Issue 3, 1999, Pages 263-266

  Myers, Joseph B ^a,b   Guskiewicz, Kevin M ^a   Riemann, Bryan L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Chinese herbal stimulants; Ephedrine; Weight loss; Wrestling

Indexed keywords

EID: 0001495671     PISSN: 10626050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Brownell KD, Steen SN, Wilmore JH. Weight regulation in athletes: analysis of metabolic and health effects. Med Sci Sports Exerc. 1987;19: 546-556.
2. Woods ER, Wilson CD, Masland RP Jr. Weight control methods in high school wrestlers. J Adolesc Health Care. 1988;9:394-397.
3. Yarrows SA. Weight loss through dehydration in amateur wrestling. J Am Diet Assoc. 1988;88:491-493.
4. White LM, Gardner SF, Gurley BJ, Marx MA, Wang PL, Estes M. Pharmacokinetics and cardiovascular effects of ma-huang (Ephedra sinica) in normotensive adults. J Clin Pharmacol. 1997;37:116-122.
5. Gurley BJ, Gardner SF, White LM, Wang PL. Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang). Ther Drug Monit. 1998;20:439-445.
6. Chan TY, Critchley JA. Usage and adverse effects of Chinese herbal medicines. Hum Exp Toxicol. 1996;15:5-12.
7. Ernst E. Harmless herbs? A review of the recent literature. Am J Med. 1998;104:170-178.
8. Vann A. The herbal medicine boom: understanding what patients are taking. Cleve Clin J Med. 1998;65:129-134.
9. Love L. Regulatory and safety issues regarding special nutritional products. J Toxicol Clin Toxicol. 1998;36:263-265.
10. Chan TY. Monitoring the safety of herbal medicines. Drug Saf. 1997;17: 209-215.
11. DeSmet PA. Should herbal medicine-like products be licensed as medicines. BMJ. 1995;310:1023-1024.
12. Delbanco TL. Bitter herbs: mainstream, magic, and menace. Ann Intern Med. 1994;121:803-804.
13. Marwick CH. Growing use of medicinal botanicals forces assessment by drug regulators. JAMA. 1995;273:607-609.
14. Kessler DA. Introducing MEDWatch: a new approach to reporting medication and device adverse effects and product problems. JAMA. 1993;269:2765-2768.
15. Food and Drug Administration. FDA Statement on Street Drugs Containing Botanical Ephedrine. Rockville, MD: National Press Office; April 10, 1996.
16. Food and Drug Administration. Dietary supplements containing ephedrine alkaloids: proposed rule. 62 Federal Register Part II, 21 CHR Part III 30678-30724 (1997).
17. FDA proposes constraints on ephedrine dietary supplements. Am J Health Syst Pharm. 1997;54:1578.
18. Theoharides TC. Sudden death of a healthy college student related to ephedrine toxicity from a ma huang-containing drink. J Clin Psychopharmacol. 1997;17:437-439.
19. Adverse events associated with ephedrine-containing products: Texas, December 1993-September 1995. JAMA. 1996;276:1711-1712.
20. Kapoor WN, Karpf M, Wieand S, Peterson JR, Levey GS. A prospective evaluation and follow-up of patients with syncope. New Engl J Med. 1983;309:197-204.
21. Wiener I, Tilkian AG, Palazzolo M. Coronary artery spasm and myocardial infarction in a patient with normal coronary arteries: temporal relationship to pseudoephedrine ingestion. Cathet Cardiovasc Diagn. 1990;20:51-53.
22. Derreza H, Fine MD, Sadaniantz A. Acute myocardial infarction after use of pseudoephedrine for sinus congestion. J Am Board Fam Pract. 1997;10:436-438.
23. Cockings JG, Brown M. Ephedrine abuse causing acute myocardial infarction. Med J Aust. 1997;167:199-200.
24. Weesner KM, Denison M, Roberts RJ. Cardiac arrhythmias in an adolescent following ingestion of an over-the-counter stimulant. Clin Pediatr (Phila). 1982;21:700-701.
25. Lake CR, Gallant S, Masson E, Miller P. Adverse drug effects attributed to phenypropanolamine: a review of 142 case reports. Am J Med. 1990;89:195-208.
26. Astrup A, Lundsgaard C, Madsen J, Christensen NJ. Enhanced thermogenic responsiveness during chronic ephedrine treatment in man. Am J Clin Nutr. 1985;42:83-94.
27. Loizou LA, Hamilton JG, Tsementzis SA. Intracranial haemorrhage in association with pseudoephedrine overdose. J Neurol Neurosurg Psychiatry. 1982;45:471-472.
28. Pentel P. Toxicity of over-the-counter stimulants. JAMA. 1984;252:1893-1903.
29. Nadir A, Agrawal S, King PD, Marshall JB. Acute hepatitis associated with use of a Chinese herbal product, ma-huang. Am J Gastroenterol. 1996;91:1436-1438.
30. Doyle H, Kargin M. Herbal stimulant containing ephedrine has also caused psychosis. BMJ. 1996;313:756.
31. Herbert WG, Ribisl PM. Effects of dehydration upon physical working capacity of wrestlers under competitive conditions. Res Q. 1972;43:416-422.
32. Hursh LM. Food and water restriction in the wrestler. JAMA. 1979;241: 915-916.
33. Maffulli N. Making weight: a case study of two elite wrestlers. Brit J Sports Med. 1992;26:107-110.
34. Burke AP, Farb A, Virmani R. Causes of sudden death in athletes. Cardiol Clinic. 1992;10:303-317.
35. Williams CC, Bernhardt DT. Syncope in athletes. Sports Med. 1995;19: 223-234.
36. Grubb BP, Temesey-Armos PN, Samoil D, Wolfe DA, Hahn H, Elliott L. Tilt table testing in the evaluation and management of athletes with recurrent exercise-induced syncope. Med Sci Sports Exerc. 1993;25:24-28.